Aegerion Pharmaceuticals, Inc. Announces Presentation At Leerink Swann and Company Global Healthcare Conference

CAMBRIDGE, Mass., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in the Leerink 2014 Global Healthcare Conference in New York City. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Wednesday, February 12, 2014 at 1:25 p.m. ET.

Help employers find you! Check out all the jobs and post your resume.